Assessment of cardiovascular disease risk in Northern China: a cross-sectional study

References

• Al-Lawati JA, Barakat MN, Al-Lawati NA, Al-Maskari MY, Elsayed MK, Mikhailidis DP, Al-Zakwani IS. 2013. Cardiovascular risk assessment in diabetes mellitus: comparison of the general Framingham risk profile versus the World Health Organization/International Society of Hypertension risk prediction charts in Arabs–clinical implications. Angiology. 64(5):336–342.
   PubMed Web of Science ®Google Scholar
• Bundy JD, He J. 2016. Hypertension and related cardiovascular disease burden in China. Ann Glob Health. 82(2):227–233.
   PubMed Web of Science ®Google Scholar
• [PCOSC] Population Census Office under the State Council, [DPESNBS] Department of Population and Employment Statistics National Bureau of Statistics. 2013. Tabulation on the 2010 population census of the People’s Republic of China. Bei Jing (BJ): China Statistics Press.
   Google Scholar
• Dhungana RR, Khanal MK, Pandey AR, Thapa P, Devkota S, Mumu SJ, Shayami A, Ali L. 2015. Assessment of short term cardiovascular risk among 40 years and above population in a selected community of Kathmandu. Nepal J Nepal Health Res Counc. 13(29):66–72.
   PubMedGoogle Scholar
• Fatema K, Zwar NA, Milton AH, Rahman B, Ali L. 2015. Application of two versions of the WHO/international society of hypertension absolute cardiovascular risk assessment tools in a rural Bangladeshi population. BMJ Open. 5(10):e008140.
   PubMed Web of Science ®Google Scholar
• Ghorpade AG, Shrivastava SR, Kar SS, Sarkar S, Majgi SM, Roy G. 2015. Estimation of the cardiovascular risk using World Health Organization/International Society of Hypertension (WHO/ISH) risk prediction charts in a rural population of South India. Int J Health Policy Manag. 4(8):531–536.
   PubMed Web of Science ®Google Scholar
• Herath HM, Weerarathna TP, Umesha D. 2015. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine. Vasc Health Risk Manag. 11:583–589.
   PubMed Web of Science ®Google Scholar
• Huang K, Song YT, He YH, Feng XL. 2016. Health system strengthening and hypertension management in China. Glob Health Res Policy. 1:13.
   PubMedGoogle Scholar
• Jin L, Guo X, Dou J, Liu B, Wang J, Li J, Sun M, et al. 2018. Multimorbidity analysis according to sex and age towards cardiovascular diseases of adults in Northeast China. Sci Rep. 8(1):8607.
   PubMed Web of Science ®Google Scholar
• Khanal MK, Ahmed MS, Moniruzzaman M, Banik PC, Dhungana RR, Bhandari P, Devkota S, Shayami A. 2017. Total cardiovascular risk for next 10 years among rural population of Nepal using WHO/ISH risk prediction chart. BMC Res Notes. 10(1):120.
   PubMedGoogle Scholar
• Kutkiene S, Petrulioniene Z, Laucevicius A, Serpytis P, Kasiulevicius V, Staigyte J, Saulyte A, et al. 2018. Cardiovascular risk assessment of dyslipidemic middle-aged adults without overt cardiovascular disease over the period of 2009–2016 in Lithuania. Lipids Health Dis. 17(1):233.
   PubMed Web of Science ®Google Scholar
• Li G, Guo G, Wang W, Wang K, Wang H, Dong F, Qian Y, et al. 2017. Association of prehypertension and cardiovascular risk factor clustering in Inner Mongolia: a cross-sectional study. BMJ Open. 7(6):e015340.
   PubMed Web of Science ®Google Scholar
• Li X, Lu J, Hu S, Cheng KK, De Maeseneer J, Meng Q, Mossialos E, et al. 2017. The primary health-care system in China. The Lancet. 390(10112):2584–2594.
   PubMed Web of Science ®Google Scholar
• Li G, Wang H, Wang K, Wang W, Dong F, Qian Y, Gong H, et al. 2016. Prevalence, awareness, treatment, control and risk factors related to hypertension among urban adults in Inner Mongolia 2014: differences between Mongolian and Han populations. BMC Public Health. 16(1):294.
   PubMed Web of Science ®Google Scholar
• Li H, Xu T, Tong W, Liu Y, Zhao L, Zhang Y. 2008. Comparison of cardiovascular risk factors between prehypertension and hypertension in a Mongolian population, Inner Mongolia, China. Circ J. 72(10):1666–1673.
   PubMed Web of Science ®Google Scholar
• Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L, Liu Y, et al. 2019. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 Global Burden of Disease Study. JAMA Cardiol. 4(4):342.
   PubMed Web of Science ®Google Scholar
• Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, et al. 2017. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). The Lancet. 390(10112):2549–2558.
   PubMed Web of Science ®Google Scholar
• [NCCD] National Center for Cardiovascular Diseases (China). 2014. Programme of screening and intervention subjects with high risk cardiovascular diseases. [accessed 2020 April 1]. https://cvdproject.nccd.org.cn/manage/login.
   Google Scholar
• Nakai M, Miyamoto Y, Higashiyama A, Murakami Y, Nishimura K, Yatsuya H, Saitoh S, EPOCH-JAPAN Research Group, et al. 2016. Calibration between the estimated probability of the risk assessment chart of Japan Atherosclerosis Society and actual mortality using external population: evidence for cardiovascular prevention from observational cohorts in Japan (EPOCH-JAPAN). J Atheroscler Thromb. 23(2):176–195.
   PubMed Web of Science ®Google Scholar
• Niu H, Tian M, Ma A, Wang C, Zhang L. 2014. Differences and determinants in access to essential public health services in China: a case study with hypertension people and under-sixes as target population. Chin Med J. 127(9):1626–1632.
   PubMed Web of Science ®Google Scholar
• Otgontuya D, Oum S, Buckley BS, Bonita R. 2013. Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia. BMC Public Health. 13(1):539.
   PubMed Web of Science ®Google Scholar
• Pancha Mbouemboue O, Derew D, Tsougmo JO, Tangyi Tamanji M. 2016. A community-based assessment of hypertension and some other cardiovascular disease risk factors in Ngaoundéré, Cameroon. Int J Hypertens. 2016:4754636.
   PubMed Web of Science ®Google Scholar
• Raghu A, Praveen D, Peiris D, Tarassenko L, Clifford G. 2015. Implications of cardiovascular disease risk assessment using the WHO/ISH risk prediction charts in rural India. PLOS One. 10(8):e0133618.
   PubMed Web of Science ®Google Scholar
• Ren Y, Ren Q, Lu J, Guo X, Huo X, Ji L, Yang X. 2018. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: a cross-sectional survey in China. Diabetes Metab Res Rev. 34(2):e2960.
   Web of Science ®Google Scholar
• Saidi O, Malouche D, O'Flaherty M, Ben Mansour N, A Skhiri H, Ben Romdhane H, Bezdah L. 2016. Assessment of cardiovascular risk in Tunisia: applying the Framingham risk score to national survey data. BMJ Open. 6(11):e009195.
   PubMed Web of Science ®Google Scholar
• Shepard D, Vanderzanden A, Moran A, Naghavi M, Murray C, Roth G. 2015. Ischemic heart disease worldwide, 1990 to 2013: estimates from the global burden of disease study 2013. Circ Cardiovasc Qual Outcomes. 8(4):455–456.
   PubMed Web of Science ®Google Scholar
• Wade TJ, Xia Y, Mumford JL, Wu K, Le XC, Sams E, Sanders WE. 2015. Cardiovascular disease and arsenic exposure in Inner Mongolia, China: a case control study. Environ Health. 14(1):35–35.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang X, Zhang J, He Q, Hu R, Wang L, Su D, et al. 2013. Factors associated with prevalence, awareness, treatment and control of hypertension among adults in Southern China: a community-based, cross-sectional survey. PLOS One. 8(5):e62469.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, et al. 2013. Prevalence and control of diabetes in Chinese adults. JAMA. 310(9):948–959.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2007. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Tetrahedron Lett. 54(22):2817–2820.
   Google Scholar
• World Health Organization. 2008. Pocket guidelines for assessment and management of CVD risk. https://www.who.int/cardiovascular_diseases/guidelines/Pocket_GL_information/en/.
   Google Scholar
• Yang J, Yin P, Zhou M, Ou CQ, Guo Y, Gasparrini A, Liu Y, et al. 2015. Cardiovascular mortality risk attributable to ambient temperature in China. Heart. 101(24):1966–1972.
   PubMed Web of Science ®Google Scholar
• Zhao D, Liu J, Xie W, Qi Y. 2015. Cardiovascular risk assessment: a global perspective. Nat Rev Cardiol. 12(5):301–311.
   PubMed Web of Science ®Google Scholar